Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers.

Samadder NJ, Neklason D, Snow A, Samowitz W, Cessna MH, Rowe K, Sandhu I, Boucher K, Pappas L, Smith KR, Wong J, Curtin K, Provenzale D, Burt RW.

Clin Gastroenterol Hepatol. 2019 Mar 29. pii: S1542-3565(19)30246-0. doi: 10.1016/j.cgh.2019.02.040. [Epub ahead of print]

PMID:
30930275
2.

MicroRNA-messenger RNA interactions involving JAK-STAT signaling genes in colorectal cancer.

Mullany LE, Herrick JS, Sakoda LC, Samowitz W, Stevens JR, Wolff RK, Slattery ML.

Genes Cancer. 2018 May;9(5-6):232-246. doi: 10.18632/genesandcancer.177.

3.

Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.

Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW.

BMC Gastroenterol. 2018 Jul 16;18(1):115. doi: 10.1186/s12876-018-0841-8.

4.

The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs.

Pellatt AJ, Mullany LE, Herrick JS, Sakoda LC, Wolff RK, Samowitz WS, Slattery ML.

J Transl Med. 2018 Jul 9;16(1):191. doi: 10.1186/s12967-018-1566-8.

5.

The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs.

Slattery ML, Mullany LE, Wolff RK, Sakoda LC, Samowitz WS, Herrick JS.

Genomics. 2019 Jul;111(4):762-771. doi: 10.1016/j.ygeno.2018.05.006. Epub 2018 Jun 1.

6.

miRNA involvement in cell cycle regulation in colorectal cancer cases.

Mullany LE, Herrick JS, Sakoda LC, Samowitz W, Stevens JR, Wolff RK, Slattery ML.

Genes Cancer. 2018 Jan;9(1-2):53-65. doi: 10.18632/genesandcancer.167.

7.

The MAPK-Signaling Pathway in Colorectal Cancer: Dysregulated Genes and Their Association With MicroRNAs.

Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Samowitz WS, Herrick JS.

Cancer Inform. 2018 Mar 26;17:1176935118766522. doi: 10.1177/1176935118766522. eCollection 2018.

8.

Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile.

Dehghanizadeh S, Khoddami V, Mosbruger TL, Hammoud SS, Edes K, Berry TS, Done M, Samowitz WS, DiSario JA, Luba DG, Burt RW, Jones DA.

PLoS One. 2018 Mar 28;13(3):e0192499. doi: 10.1371/journal.pone.0192499. eCollection 2018.

9.

Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers.

Wolff RK, Hoffman MD, Wolff EC, Herrick JS, Sakoda LC, Samowitz WS, Slattery ML.

Genes Chromosomes Cancer. 2018 Jul;57(7):366-376. doi: 10.1002/gcc.22539. Epub 2018 Apr 30.

10.

Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients.

Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Samowitz WS, Herrick JS.

Apoptosis. 2018 Apr;23(3-4):237-250. doi: 10.1007/s10495-018-1451-1.

11.

Expression of Wnt-signaling pathway genes and their associations with miRNAs in colorectal cancer.

Slattery ML, Mullany LE, Sakoda LC, Samowitz WS, Wolff RK, Stevens JR, Herrick JS.

Oncotarget. 2017 Dec 23;9(5):6075-6085. doi: 10.18632/oncotarget.23636. eCollection 2018 Jan 19.

12.

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.

Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW.

JAMA Oncol. 2018 May 1;4(5):671-677. doi: 10.1001/jamaoncol.2017.5431.

13.

Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype.

Slattery ML, Lee FY, Pellatt AJ, Mullany LE, Stevens JR, Samowitz WS, Wolff RK, Herrick JS.

Mod Pathol. 2018 Jan;31(1):209. doi: 10.1038/modpathol.2017.118.

14.

MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases.

Mullany LE, Herrick JS, Wolff RK, Stevens JR, Samowitz W, Slattery ML.

Genes Chromosomes Cancer. 2018 Apr;57(4):192-202. doi: 10.1002/gcc.22520. Epub 2017 Dec 29.

15.

The NF-κB signalling pathway in colorectal cancer: associations between dysregulated gene and miRNA expression.

Slattery ML, Mullany LE, Sakoda L, Samowitz WS, Wolff RK, Stevens JR, Herrick JS.

J Cancer Res Clin Oncol. 2018 Feb;144(2):269-283. doi: 10.1007/s00432-017-2548-6. Epub 2017 Nov 29.

16.

Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer.

Slattery ML, Pellatt AJ, Lee FY, Herrick JS, Samowitz WS, Stevens JR, Wolff RK, Mullany LE.

Oncotarget. 2017 Aug 3;8(48):83845-83859. doi: 10.18632/oncotarget.19863. eCollection 2017 Oct 13.

17.

Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.

Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason DW.

Cancer Prev Res (Phila). 2018 Jan;11(1):4-15. doi: 10.1158/1940-6207.CAPR-17-0130. Epub 2017 Nov 6.

18.

The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer.

Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Stevens JR, Samowitz WS, Herrick JS.

Mol Carcinog. 2018 Feb;57(2):243-261. doi: 10.1002/mc.22752. Epub 2017 Nov 19.

19.

The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.

Slattery ML, Herrick JS, Mullany LE, Samowitz WS, Sevens JR, Sakoda L, Wolff RK.

Genes Chromosomes Cancer. 2017 Nov;56(11):769-787. doi: 10.1002/gcc.22481. Epub 2017 Jul 30.

20.

Transcription factor-microRNA associations and their impact on colorectal cancer survival.

Mullany LE, Herrick JS, Wolff RK, Stevens JR, Samowitz W, Slattery ML.

Mol Carcinog. 2017 Nov;56(11):2512-2526. doi: 10.1002/mc.22698. Epub 2017 Aug 3.

21.

Colon Pathology Characteristics in Li-Fraumeni Syndrome.

Rengifo-Cam W, Shepherd HM, Jasperson KW, Samadder NJ, Samowitz W, Tripp SR, Schiffman JD, Kohlmann W.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):140-141. doi: 10.1016/j.cgh.2017.06.017. Epub 2017 Jun 15. No abstract available.

22.

Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.

Furtado LV, Samowitz WS.

Virchows Arch. 2017 Aug;471(2):235-242. doi: 10.1007/s00428-017-2153-8. Epub 2017 May 27. Review.

PMID:
28551725
23.

Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype.

Slattery ML, Lee FY, Pellatt AJ, Mullany LE, Stevens JR, Samowitz WS, Wolff RK, Herrick JS.

Mod Pathol. 2017 Aug;30(8):1152-1169. doi: 10.1038/modpathol.2017.38. Epub 2017 May 26. Erratum in: Mod Pathol. 2018 Jan;31(1):209.

24.

A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management.

Lloyd IE, Kohlmann WK, Gligorich K, Hall A, Lyon E, Downs-Kelly E, Samowitz WS, Bronner MP.

Am J Gastroenterol. 2017 Jul;112(7):1094-1102. doi: 10.1038/ajg.2017.125. Epub 2017 May 2.

PMID:
28462913
25.

Feasibility of Large-Scale Identification of Sessile Serrated Polyp Patients Using Electronic Records: A Utah Study.

Affolter K, Gligorich K, Samadder NJ, Samowitz WS, Curtin K.

Dig Dis Sci. 2017 Jun;62(6):1455-1463. doi: 10.1007/s10620-017-4543-9. Epub 2017 Mar 17.

PMID:
28315031
26.

A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency.

Rengifo-Cam W, Jasperson K, Garrido-Laguna I, Colman H, Scaife C, Samowitz W, Samadder NJ.

ACG Case Rep J. 2017 Mar 1;4:e34. doi: 10.14309/crj.2017.34. eCollection 2017.

27.

Doxycycline-induced gastrointestinal injury.

Affolter K, Samowitz W, Boynton K, Kelly ED.

Hum Pathol. 2017 Aug;66:212-215. doi: 10.1016/j.humpath.2017.02.011. Epub 2017 Mar 9.

PMID:
28286288
28.

The miRNA landscape of colorectal polyps.

Slattery ML, Herrick JS, Wolff RK, Mullany LE, Stevens JR, Samowitz W.

Genes Chromosomes Cancer. 2017 May;56(5):347-353. doi: 10.1002/gcc.22436. Epub 2017 Feb 1.

29.

Site-specific associations between miRNA expression and survival in colorectal cancer cases.

Slattery ML, Herrick JS, Pellatt DF, Mullany LE, Stevens JR, Wolff E, Hoffman MD, Wolff RK, Samowitz W.

Oncotarget. 2016 Sep 13;7(37):60193-60205. doi: 10.18632/oncotarget.11173.

30.

Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK.

JAMA. 2016 Mar 22-29;315(12):1266-75. doi: 10.1001/jama.2016.2522.

31.

Diagnostic Challenges Caused by Endoscopic Biopsy of Colonic Polyps: A Systematic Evaluation of Epithelial Misplacement With Review of Problematic Polyps From the Bowel Cancer Screening Program, United Kingdom.

Panarelli NC, Somarathna T, Samowitz WS, Kornacki S, Sanders SA, Novelli MR, Shepherd NA, Yantiss RK.

Am J Surg Pathol. 2016 Aug;40(8):1075-83. doi: 10.1097/PAS.0000000000000641.

PMID:
26975041
32.

Expression Profiles of miRNA Subsets Distinguish Human Colorectal Carcinoma and Normal Colonic Mucosa.

Pellatt DF, Stevens JR, Wolff RK, Mullany LE, Herrick JS, Samowitz W, Slattery ML.

Clin Transl Gastroenterol. 2016 Mar 10;7:e152. doi: 10.1038/ctg.2016.11.

33.

MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression.

Slattery ML, Herrick JS, Pellatt DF, Stevens JR, Mullany LE, Wolff E, Hoffman MD, Samowitz WS, Wolff RK.

Carcinogenesis. 2016 Mar;37(3):245-261. doi: 10.1093/carcin/bgv249. Epub 2016 Jan 6.

34.

Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.

Panarelli NC, Vaughn CP, Samowitz WS, Yantiss RK.

Am J Surg Pathol. 2015 Mar;39(3):313-7. doi: 10.1097/PAS.0000000000000380.

PMID:
25602793
35.

Evaluation of colorectal cancers for Lynch syndrome: practical molecular diagnostics for surgical pathologists.

Samowitz WS.

Mod Pathol. 2015 Jan;28 Suppl 1:S109-13. doi: 10.1038/modpathol.2014.127. Review.

36.

An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.

Slattery ML, Herrick JS, Mullany LE, Valeri N, Stevens J, Caan BJ, Samowitz W, Wolff RK.

Int J Cancer. 2015 Jul 15;137(2):428-38. doi: 10.1002/ijc.29384. Epub 2014 Dec 16.

37.

Dance well: partnering with reference laboratories for oncology testing.

Grossmann AH, Samowitz W, Cohen M.

Arch Pathol Lab Med. 2015 May;139(5):585-6. doi: 10.5858/arpa.2014-0023-ED. Epub 2014 Sep 23. Review. No abstract available.

PMID:
25248093
38.

ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis).

Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A; Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee.

Genet Med. 2014 Jan;16(1):101-16. doi: 10.1038/gim.2013.166. Epub 2013 Dec 5.

PMID:
24310308
39.

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.

Bartley AN, Hamilton SR, Alsabeh R, Ambinder EP, Berman M, Collins E, Fitzgibbons PL, Gress DM, Nowak JA, Samowitz WS, Zafar SY; Members of the Cancer Biomarker Reporting Workgroup, College of American Pathologists.

Arch Pathol Lab Med. 2014 Feb;138(2):166-70. doi: 10.5858/arpa.2013-0231-CP. Epub 2013 Jun 28. No abstract available.

PMID:
23808403
40.

BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.

Affolter K, Samowitz W, Tripp S, Bronner MP.

Genes Chromosomes Cancer. 2013 Aug;52(8):748-52. doi: 10.1002/gcc.22070. Epub 2013 May 7.

PMID:
23650027
41.

Molecular Pathology of Gastrointestinal Cancer.

Yantiss RK, Samowitz WS.

Surg Pathol Clin. 2012 Dec;5(4):821-42. doi: 10.1016/j.path.2012.08.002. Epub 2012 Sep 30.

PMID:
26838505
42.

The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.

Vaughn CP, Baker CL, Samowitz WS, Swensen JJ.

Genes Chromosomes Cancer. 2013 Jan;52(1):107-12. doi: 10.1002/gcc.22011. Epub 2012 Sep 25.

PMID:
23012243
43.

Recurrent and founder mutations in the PMS2 gene.

Tomsic J, Senter L, Liyanarachchi S, Clendenning M, Vaughn CP, Jenkins MA, Hopper JL, Young J, Samowitz W, de la Chapelle A.

Clin Genet. 2013 Mar;83(3):238-43. doi: 10.1111/j.1399-0004.2012.01898.x. Epub 2012 Jun 4.

44.

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, Heichman KA.

BMC Med. 2011 Dec 14;9:133. doi: 10.1186/1741-7015-9-133.

45.

A PIK3CA pyrosequencing-based assay that excludes pseudogene interference.

Baker CL, Vaughn CP, Samowitz WS.

J Mol Diagn. 2012 Jan;14(1):56-60. doi: 10.1016/j.jmoldx.2011.08.004. Epub 2011 Oct 24.

PMID:
22026957
46.

Epidermal growth factor receptor pathway mutations and colorectal cancer therapy.

Grossmann AH, Samowitz WS.

Arch Pathol Lab Med. 2011 Oct;135(10):1278-82. doi: 10.5858/arpa.2011-0047-RA. Review.

PMID:
21970483
47.

Microsatellite instability and colorectal cancer.

Geiersbach KB, Samowitz WS.

Arch Pathol Lab Med. 2011 Oct;135(10):1269-77. doi: 10.5858/arpa.2011-0035-RA. Review.

PMID:
21970482
48.

Lynch syndrome screening implementation: business analysis by a healthcare system.

Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS.

Am J Manag Care. 2011 Aug 1;17(8):e288-300.

PMID:
21851136
49.

Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.

Vaughn CP, Hart KJ, Samowitz WS, Swensen JJ.

Hum Mutat. 2011 Sep;32(9):1063-71. doi: 10.1002/humu.21540.

PMID:
21618646
50.

CpG island methylation in colorectal cancer: past, present and future.

Curtin K, Slattery ML, Samowitz WS.

Patholog Res Int. 2011 Apr 12;2011:902674. doi: 10.4061/2011/902674.

Supplemental Content

Loading ...
Support Center